Combined effect of obesity and metabolic profile on glomerular dysfunction in hypertensive subjects

The aim of this study is to explore the individual and combined effects of obesity and metabolic profile on the impairment of glomerular function among hypertensive subjects.

[1]  T. Jenssen,et al.  Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population. , 2018, Kidney international.

[2]  D. Zanetta,et al.  Aging and decreased glomerular filtration rate: An elderly population-based study , 2017, PloS one.

[3]  J. Caramori,et al.  Recognition of visceral obesity beyond body fat: assessment of cardiovascular risk in chronic kidney disease using anthropometry , 2017, Nutrire.

[4]  Bruce W Bailey,et al.  Expanded Normal Weight Obesity and Insulin Resistance in US Adults of the National Health and Nutrition Examination Survey , 2017, Journal of diabetes research.

[5]  C. Lee,et al.  Effect of synergistic interaction between abnormal adiposity-related metabolism and prediabetes on microalbuminuria in the general population , 2017, PloS one.

[6]  Jianghua Chen,et al.  Combined effect of body mass index and metabolic status on the risk of prevalent and incident chronic kidney disease: a systematic review and meta-analysis , 2016, Oncotarget.

[7]  P. Valensi,et al.  Are Obese Individuals with no Feature of Metabolic Syndrome but Increased Waist Circumference Really Healthy? A Cross Sectional Study. , 2016, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[8]  N. Nakamura,et al.  Metabolically healthy obesity and risk of incident CKD. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[9]  K. Sharma,et al.  Obesity and kidney disease: differential effects of obesity on adipose tissue and kidney inflammation and fibrosis , 2015, Current opinion in nephrology and hypertension.

[10]  Hongmei Li,et al.  Interaction of Obesity and Central Obesity on Elevated Urinary Albumin-to-Creatinine Ratio , 2014, PloS one.

[11]  W. Gulliver,et al.  Body fat percentage is associated with cardiometabolic dysregulation in BMI-defined normal weight subjects. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[12]  L. Weinrauch,et al.  Pathophysiology of Obesity-Related Renal Dysfunction Contributes to Diabetic Nephropathy , 2012, Current Diabetes Reports.

[13]  E. Randell,et al.  The Prevalence of Metabolically Healthy Obese Subjects Defined by BMI and Dual‐Energy X‐Ray Absorptiometry , 2011, Obesity.

[14]  Tyler J. VanderWeele,et al.  Estimating measures of interaction on an additive scale for preventive exposures , 2011, European Journal of Epidemiology.

[15]  F Paccaud,et al.  Normal weight obesity: relationship with lipids, glycaemic status, liver enzymes and inflammation. , 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[16]  G. Parati,et al.  Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. , 2010, European heart journal.

[17]  B. Kasiske,et al.  Kidney Disease: Improving Global Outcomes , 2009, Nature Reviews Nephrology.

[18]  R. Mak,et al.  Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[19]  R. Lipsy.  Introduction , 2003, Journal of managed care pharmacy : JMCP.

[20]  A. Ahlbom,et al.  How to evaluate interaction between causes: a review of practices in cardiovascular epidemiology , 1996, Journal of internal medicine.

[21]  Christine Maric-Bilkan.  Obesity and diabetic kidney disease. , 2013, The Medical clinics of North America.